James T. Parsons

Insider Reports History

Entity
Individual
Location
2 Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James T. Parsons:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 59.9K $168K $2.80 Jun 1, 2024 Direct
DiaMedica Therapeutics Inc. Director Stock Option (right to buy) 28.5K Jun 1, 2024 Direct
Trillium Therapeutics Inc. Chief Financial Officer Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by James T. Parsons

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 Director
DMAC DiaMedica Therapeutics Inc. Jan 2, 2024 1 $60K 4 Jan 2, 2024 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jan 3, 2022 1 $60K 4 Jan 3, 2022 Director
TRIL Trillium Therapeutics Inc. Nov 17, 2021 8 $0 4 Nov 19, 2021 Chief Financial Officer
DMAC DiaMedica Therapeutics Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director